Most weight lost with GLP-1 obesity drugs came from fat, while relative muscle mass was largely preserved. GLP-1 obesity drugs can lead to substantial weight loss, but an important question is what the body is actually losing. New research presented at the European Congress on Obesity (ECO2026) suggests that 80-85% of weight lost during treatment [...]

Semaglutide delivered dramatic weight loss and health benefits in adults over 65, offering new hope for healthier aging. A new analysis of data from the STEP clinical trial program suggests that semaglutide remains both effective and generally safe for older adults living with obesity. The research, conducted by Prof. Luca Busetto of the University of [...]